Eastern Bank Invests $15.82 Million in Agilent Technologies, Inc. (NYSE:A)

Eastern Bank bought a new position in Agilent Technologies, Inc. (NYSE:A) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 106,534 shares of the medical research company’s stock, valued at approximately $15,818,000.

Several other institutional investors have also recently made changes to their positions in A. Crewe Advisors LLC boosted its stake in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Livelsberger Financial Advisory purchased a new stake in Agilent Technologies during the 3rd quarter valued at $28,000. Ridgewood Investments LLC purchased a new position in shares of Agilent Technologies in the 2nd quarter worth $29,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Agilent Technologies in the 2nd quarter worth $39,000. Finally, Riverview Trust Co purchased a new position in shares of Agilent Technologies in the 1st quarter worth $41,000. Institutional investors own 87.42% of the company’s stock.

Wall Street Analyst Weigh In

A has been the topic of a number of research reports. Evercore ISI raised their price target on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Wells Fargo & Company initiated coverage on Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price target on the stock. TD Cowen raised their price target on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Bank of America raised their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Finally, Citigroup lifted their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $144.36.

Agilent Technologies Trading Down 2.1 %

NYSE A traded down $2.93 during trading hours on Tuesday, hitting $133.83. 737,920 shares of the company were exchanged, compared to its average volume of 1,681,369. The stock has a 50-day moving average price of $141.05 and a 200 day moving average price of $138.70. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $155.35. The stock has a market cap of $39.05 billion, a PE ratio of 32.33, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the business earned $1.43 earnings per share. The company’s revenue for the quarter was down 5.6% compared to the same quarter last year. Analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be paid a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,953 shares of company stock valued at $2,013,630 over the last 90 days. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.